CIK 0001579428 · Large accelerated filer
Axsome Therapeutics, Inc.
Sign in to watch- Ticker
- AXSM
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 454241907
- Phone
- (212) 332-3241
- Business address
- ONE WORLD TRADE CENTER, 29TH FLOOR, NEW YORK, NY, 10007
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $2,086,500
- in 1 filing, $2.1M under 10b5-1 plans
Net −$2,086,500. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2016-05-27 | JEFFS ROGER Director | Grant or award · Stock Option (Right to Buy) | +5,193 | 5,193 | ||
| 2015-12-23 | Kaye Randall Chief Medical Officer | Purchase | +1,000 | $9.03 | $9K | 6,022 |
| 2015-11-24 | Ames Constance Vice President, Finance | Conversion | +4,358 | $5.94 | $26K | 4,358 |
| 2015-11-24 | Ames Constance Vice President, Finance | Grant or award · 8% Convertible Note | +4,358 | 0 | ||
| 2015-11-24 | Kaye Randall Chief Medical Officer | Conversion | +5,022 | $5.40 | $27K | 5,022 |
| 2015-11-24 | Kaye Randall Chief Medical Officer | Grant or award · 8% Convertible Note | +5,022 | 0 | ||
| 2015-11-24 | Coleman Mark Director | Conversion | +243,750 | $5.40 | $1.3M | 326,800 |
| 2015-11-24 | Coleman Mark Director | Conversion | +180,526 | $5.94 | $1.1M | 507,326 |
| 2015-11-24 | Coleman Mark Director | Conversion | +140,672 | $5.94 | $836K | 647,998 |
| 2015-11-24 | Coleman Mark Director | Grant or award · 8% Convertible Note | +243,750 | 0 | ||
| 2015-11-24 | Coleman Mark Director | Grant or award · 8% Convertible Note | +180,526 | 0 | ||
| 2015-11-24 | Coleman Mark Director | Grant or award · 8% Convertible Note | +140,672 | 0 | ||
| 2015-11-24 | JEFFS ROGER Director | Conversion | +4,374 | $5.94 | $26K | 4,374 |
| 2015-11-24 | JEFFS ROGER Director | Grant or award · 8% Convertible Note | +4,374 | 0 | ||
| 2015-11-24 | Saad Mark E Director | Conversion | +3,502 | $5.94 | $21K | 3,502 |
| 2015-11-24 | Saad Mark E Director | Grant or award · 8% Convertible Note | +3,502 | 0 | ||
| 2015-11-24 | TABUTEAU HERRIOT Chief Executive Officer | Conversion | +7,229 | $5.94 | $43K | 7,229 |
| 2015-11-24 | TABUTEAU HERRIOT Chief Executive Officer | Grant or award · 8% Convertible Note | +7,229 | 0 | ||
| 2015-11-19 | Ames Constance Vice President, Finance | Grant or award · Employee Stock Option (Right to Buy) | +40,673 | 40,673 | ||
| 2015-11-19 | Coleman Mark Director | Grant or award · Employee Stock Option (Right to Buy) | +9,127 | 9,127 |
Page 21 of 22 · 422 trades